Financials data is unavailable for this security.
View more
Year on year 4Basebio PLC 's revenues fell -20.71% from 338.00k to 268.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 3.24m to a larger loss of 5.15m.
Gross margin | 80.51% |
---|---|
Net profit margin | -1,772.60% |
Operating margin | -1,946.33% |
Return on assets | -52.42% |
---|---|
Return on equity | -97.29% |
Return on investment | -60.21% |
More ▼
Cash flow in GBPView more
In 2022, cash reserves at 4Basebio PLC fell by 5.24m. Cash Flow from Financing totalled 1.24m or 464.18% of revenues. In addition the company used 4.70m for operations while cash used for investing totalled 1.94m.
Cash flow per share | -0.4611 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2769 |
---|---|
Tangible book value per share | 0.0848 |
More ▼
Balance sheet in GBPView more
Current ratio | 3.42 |
---|---|
Quick ratio | 3.28 |
Total debt/total equity | 2.01 |
---|---|
Total debt/total capital | 0.6683 |
More ▼